Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa once-weekly versus three-times-weekly dosing for chemotherapy-associated anemia
2006-000914-19Phase 4Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of epoetin alfa in anaemia and cancer (2 arms), sponsored by Janssen Pharmaceutical. Started Jul 2006; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anaemiacancer
Beyond the preview
Go deeper on 2006-000914-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000914-19.